Insider Trading April 30, 2026 06:42 PM

Qualcomm Executive Disposes of Shares Amid Mixed Market Guidance and Price Target Shifts

SVP Patricia Grech executes Rule 10b5-1 sale as semiconductor giant navigates shifting handset demand in China.

By Derek Hwang QCOM
Qualcomm Executive Disposes of Shares Amid Mixed Market Guidance and Price Target Shifts
QCOM

Patricia Y. Grech, the Senior Vice President and Chief Accounting Officer at Qualcomm Inc/DE (NASDAQ: QCOM), recently completed a sale of company common stock. The transaction, which took place on April 30, 2026, involved the disposal of 192 shares at a price point of $172.0 per share, totaling a value of $33,024. This divestment was carried out under the framework of a Rule 10b5-1 trading plan that had been established on December 11, 2025.The shares involved in this sale were held indirectly by a family trust, managed by Ms. Grech and her spouse as trustees, with immediate family members serving as the beneficiaries. Following the completion of this transaction, Ms. Grech's indirect ownership of common stock within that specific trust stands at zero shares.Since the date of the sale, Qualcomm's stock has experienced significant movement, surging 34% over the past week to reach a current trading price of $179.54. This represents a notable increase from the $172 price realized during Ms. Grech's transaction. Currently, the semiconductor company maintains a market valuation of $191.6 billion, trading at a P/E ratio of 36.55 and providing a dividend yield of 2.05%.

Key Points

  • <strong>Insider Divestment:</strong> SVP Patricia Grech executed a planned sale of 192 shares via a 10b5-1 plan, impacting individual executive holdings within a family trust.
  • <strong>Revenue Guidance Divergence:</strong> While meeting recent quarterly revenue expectations of $10.6 billion, Qualcomm's guidance for the June quarter ($9.6 billion) indicates a 9% sequential decline, signaling potential volatility in the semiconductor and handset sectors.
  • <strong>Sector Pivot:</strong> Analysts are increasingly weighing the impact of weakened demand in the China Android market against emerging growth drivers in the data center sector.

Qualcomm Inc/DE (NASDAQ: QCOM) has seen recent insider activity as Senior Vice President and Chief Accounting Officer Patricia Y. Grech liquidated a portion of her indirect holdings. On April 30, 2026, Ms. Grech sold 192 shares of common stock at $172.0 per share, resulting in a total transaction value of $33,024. This sale was facilitated through a Rule 10b5-1 trading plan adopted on December 11, 2025. The assets were held via a family trust where Ms. Grech and her spouse act as trustees for the benefit of immediate family members. Post-transaction, the indirect holdings in this trust have been reduced to zero.


Market Performance and Valuation

Despite the executive sale, Qualcomm's stock has demonstrated substantial upward momentum in recent sessions. The shares have climbed 34% over the last week, with a current trading price of $179.54. This follows the $172 execution price noted in the insider filing. With a market capitalization of $191.6 billion, the semiconductor firm is currently valued at a P/E ratio of 36.55 and offers investors a dividend yield of 2.05%. Some analyses suggest that at these current levels, QCOM may be undervalued.


Operational Outlook and Sector Impact

The company's recent financial reporting presents a complex picture for the semiconductor and consumer electronics sectors. While Qualcomm reported fiscal second-quarter revenue of $10.6 billion, which aligned with market expectations, its forward-looking guidance suggests upcoming headwinds. The company projected revenue of $9.6 billion for the June quarter, representing a sequential decline of 9%. This projection falls below consensus estimates and is largely attributed to softening demand in the handset market, specifically within the China Android segment.

KeyBanc analysts identified reduced demand from Chinese manufacturers as a primary driver behind these trends. The fluctuations in handset demand highlight the sensitivity of the semiconductor industry to regional consumer electronics cycles and manufacturing adjustments.


Analyst Sentiment and Price Targets

Financial institutions have responded to these developments with varying degrees of optimism regarding Qualcomm's future trajectory, particularly concerning its data center prospects. Several major firms have adjusted their price targets:

  • JPMorgan: Raised its target to $160, citing the company's leadership in technology.
  • UBS: Increased its target to $170, noting potential growth opportunities within the data center sector.
  • BofA Securities: Set a price target of $165; however, they maintained an Underperform rating, citing stable handset sell-through contrasted by reduced shipments due to inventory adjustments.
  • Mizuho: Maintained a Neutral rating while establishing a new price target of $170, echoing optimism regarding data center opportunities.

The divergence in analyst views underscores a period of transition for Qualcomm as it balances challenges in the mobile handset market against emerging opportunities in higher-growth computing sectors.

Risks

  • <strong>Regional Demand Weakness:</strong> Reduced demand from Chinese manufacturers for Android handsets poses a direct risk to Qualcomm's revenue streams and broader consumer electronics markets.
  • <strong>Inventory and Shipment Volatility:</strong> As noted by BofA Securities, inventory adjustments are leading to reduced shipments, creating uncertainty in short-term hardware cycles.
  • <strong>Guidance Misses:</strong> The projected 9% sequential drop in revenue for the upcoming quarter highlights the risk of failing to meet consensus market expectations.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026